Antihelminthics Market Research Report- Forecast till 2027

Antihelminthics Market Information: By Type (Benzimidazoles, Abamectin, Salicylanilides, Praziquantel), Application (Schistosomiasis, Fasciolasis, Filariasis, Angiostrongylosis, Ascariasis, Giardiasis), End User (Hospital)-Forecast till 2027

ID: MRFR/Pharma/3086-HCR | August 2022 | Region: Global | 85 Pages         

BRIEF TOC

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Antihelminthics Market, by Type

6.1 Introduction

6.2 Benzimidazoles

Market Estimates & Forecast, 2020 – 2027

6.2.1 Albendazole

Market Estimates & Forecast, 2020 – 2027

6.2.2 Mebendazole

Market Estimates & Forecast, 2020 – 2027

6.2.3 Benzimidazoles

Market Estimates & Forecast, 2020 – 2027

6.2.4 Thiabendazole

Market Estimates & Forecast, 2020 – 2027

6.2.5 Others

Market Estimates & Forecast, 2020 – 2027

6.3 Abamectin

Market Estimates & Forecast, 2020 – 2027

6.4 Salicylanilides

Market Estimates & Forecast, 2020 – 2027

6.5 Praziquantel

Market Estimates & Forecast, 2020 – 2027

6.6 Others

Market Estimates & Forecast, 2020 – 2027

Chapter 7. Global Antihelminthics Market, by Applications

7.1 Introduction

7.2 Schistosomiasis

Market Estimates & Forecast, 2020 – 2027

7.3 Fasciolasis

Market Estimates & Forecast, 2020 – 2027

7.4 Filariasis

Market Estimates & Forecast, 2020 – 2027

7.5 Angiostrongylosis

Market Estimates & Forecast, 2020 – 2027

7.6 Ascariasis

Market Estimates & Forecast, 2020 – 2027

7.7 Giardiasis

Market Estimates & Forecast, 2020 – 2027

7.8 Others

Market Estimates & Forecast, 2020 – 2027

Chapter 8 Global Antihelminthics Market, by End User

8.1 Introduction

8.2 Hospitals

8.2.1 Market Estimates & Forecast, 2020 – 2027

8.3 Clinics

8.2.2 Market Estimates & Forecast, 2020 – 2027

8.4 Others

Chapter 9. Global Antihelminthics Market, by Region

9.1 Introduction

9.2 America

9.2.1 North America

9.2.1.1 US

9.2.1.1 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest of the Middle East & Africa

Chapter 10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

Chapter 11 Company Profiles

11.1 Novartis AG

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Abbott

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 ZEISS International

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Johnson & Johnson Services, Inc

11.4.1 Company Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Sanofi

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.6 Merck & Co., Inc.

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.7 GlaxoSmithKline plc

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Antihelminthics industry

Chapter 13 Appendix

LIST OF TABLES

Table 1 Antihelminthics Industry Synopsis, 2020 – 2027

Table 2 Global Antihelminthics Market Estimates and Forecast, 2020 – 2027, (USD Million)

Table 3 Global Antihelminthics Market by Region, 2020 – 2027, (USD Million)

Table 4 Global Antihelminthics Market by Types, 2020 – 2027, (USD Million)

Table 5 Global Antihelminthics Market by Applications, 2020 – 2027, (USD Million)

Table 6 Global Antihelminthics Market by End Users, 2020 – 2027, (USD Million)

Table 7 North America Antihelminthics Market by Types, 2020 – 2027, (USD Million)

Table 8 North America Antihelminthics Market by Applications, 2020 – 2027, (USD Million)

Table 9 North America Antihelminthics Market by End Users, 2020 – 2027, (USD Million)

Table 10 US Market by Types, 2020 – 2027, (USD Million)

Table 11 US Antihelminthics Market by Applications, 2020 – 2027, (USD Million)

Table 12 US Antihelminthics Market by End Users, 2020 – 2027, (USD Million)

Table 13 Canada Market by Types, 2020 – 2027, (USD Million)

Table 14 Canada Antihelminthics Market by Applications, 2020 – 2027, (USD Million)

Table 15 Canada Antihelminthics Market by End Users, 2020 – 2027, (USD Million)

Table 16 South America Market by Types, 2020 – 2027, (USD Million)

Table 17 South America Antihelminthics Market by Applications, 2020 – 2027, (USD Million)

Table 18 South America Antihelminthics Market by End Users, 2020 – 2027, (USD Million)

Table 19 Europe Market by Types, 2020 – 2027, (USD Million)

Table 20 Europe Antihelminthics Market by Applications, 2020 – 2027, (USD Million)

Table 21 Europe Antihelminthics Market by End Users, 2020 – 2027, (USD Million)

Table 22 Western Europe Market by Types, 2020 – 2027, (USD Million)

Table 23 Western Europe Antihelminthics Market by Applications, 2020 – 2027, (USD Million)

Table 24 Western Europe Antihelminthics Market by End Users, 2020 – 2027, (USD Million)

Table 25 Eastern Europe Market by Types, 2020 – 2027, (USD Million)

Table 26 Eastern Europe Antihelminthics Market by Applications, 2020 – 2027, (USD Million)

Table 27 Eastern Europe Antihelminthics Market by End Users, 2020 – 2027, (USD Million)

Table 28 Asia Pacific Market by Types, 2020 – 2027, (USD Million)

Table 29 Asia Pacific Antihelminthics Market by Applications, 2020 – 2027, (USD Million)

Table 30 Asia Pacific Antihelminthics Market by End Users, 2020 – 2027, (USD Million)

Table 31 Middle East & Africa Market by Types, 2020 – 2027, (USD Million)

Table 32 Middle East & Africa Antihelminthics Market by Applications, 2020 – 2027, (USD Million)

Table 33 Middle East & Africa Antihelminthics Market by End Users, 2020 – 2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Antihelminthics Market

Figure 3 Segmentation Market Dynamics for Global Antihelminthics Market

Figure 4 Global Antihelminthics market Share, by type 2020

Figure 5 Global Antihelminthics market Share, by Applications 2020

Figure 6 Global Antihelminthics Market Share, by End Users, 2020

Figure 7 Global Antihelminthics Market Share, by Region, 2020

Figure 8 North America Antihelminthics Market Share, by Country, 2020

Figure 9 Europe Antihelminthics Market Share, by Country, 2020

Figure 10 Asia Pacific Antihelminthics Market Share, by Country, 2020

Figure 11 Middle East & Africa Antihelminthics Market Share, by Country, 2020

Figure 12 Global Antihelminthics Market: Company Share Analysis, 2020 (%)

Figure 13 Novartis AG: Key Financials

Figure 14 Novartis AG: Segmental Revenue

Figure 15 Novartis AG: Geographical Revenue

Figure 16 Abbott: Key Financials

Figure 17 Abbott: Segmental Revenue

Figure 18 Abbott: Geographical Revenue

Figure 19 ZEISS International: Key Financials

Figure 20 ZEISS International: Segmental Revenue

Figure 21 ZEISS International: Geographical Revenue

Figure 22 Johnson & Johnson Services, Inc.: Key Financials

Figure 23 Johnson & Johnson Services, Inc.: Segmental Revenue

Figure 24 Johnson & Johnson Services, Inc.: Geographical Revenue

Figure 25 Sanofi.: Key Financials

Figure 26 Sanofi.: Segmental Revenue

Figure 27 Sanofi.: Geographical Revenue

Figure 28 Merck & Co., Inc.: Key Financials

Figure 29 Merck & Co., Inc.: Segmental Revenue

Figure 30 Merck & Co., Inc.: Geographical Revenue

Figure 31 GlaxoSmithKline plc.: Key Financials

Figure 32 GlaxoSmithKline plc.: Segmental Revenue

Figure 33 GlaxoSmithKline plc.: Geographical Revenue

Antihelminthics Market Speak to Analyst Request a Free Sample

Antihelminthics Market Scenario


Antihelminthics are a group of antiparasitic drugs that kill and expel parasitic worms & other internal parasites from the body without causing any significant damage to the patient. These drugs are used for the treatment of various diseases such as fasciolasis, filariasis, angiostrongylosis, and many others. Increasing prevalence of diseases such as schistosomiasis, whipworm infection, ascariasis, and other intestinal infections have boosted the growth of the antihelminthic drugs market. According to the World Health Organization (WHO) in 2014, over 1.5 billion people were infected with soil-transmitted helminthes worldwide. Additionally, a latest report published by the WHO says that more than 880 million children are in the need of treatment for these parasitic diseases. A number of different types of antiparasitic drugs are available in the market for the treatment of the different parasitic diseases. According to a research, ascariasis remains the most common intestinal parasite with 807–1221 million infections globally. It is the most prevalent diseases in East Asia, sub-Saharan Africa, and India. Majority of the patients are in developing region due to unhygienic condition. Over 65% of the patient population suffering from parasitic diseases are present in East Asia, sub-Saharan Africa, and India. Moreover, increasing geriatric population, rapidly developing healthcare sector, and increasing demand for the treatment of the parasitic diseases have fuelled the market growth. On the other hand, the side effects associated with the treatment may slow the market growth over the review period.


The global antihelminthics market is expected to grow at a CAGR of ~5.3 % during the forecast period 2017-2023.


 Figure 1: Global Antihelminthics Market, by Types


Share, 2016 (%) Antihelminthics Market

                  Sources: WHO, annual reports, press release, white paper, company presentation


Segmentations


The global antihelminthics market is segmented on the basis of types, application, and end user.


On the basis of types, the antihelminthics market is segmented into benzimidazoles, abamectin, salicylanilides, praziquantel and others. Benzimidazoles is further segmented into albendazole, mebendazole, benzimidazoles, thiabendazole, and others. Salicylanilides is further segmented into niclosamide, oxyclozanide, rafoxanide, and others.


On the basis of applications, the market is segmented into schistosomiasis, fasciolasis, filariasis, angiostrongylosis, ascariasis, giardiasis and others.


On the basis of end user, the antihelminthics market is segmented into hospitals, clinics, and others.


On the basis types, benzimidazoles holds the major share in the market due to their long history and efficiency. A number of different types of benzimidazoles are available in the market, however, certain side effects are observed in the patient, which may slow the growth of the benzimidazoles market. 


Research Methodology Antihelminthics Market-


Sources: WHO, annual reports, press release, white paper, and company presentation


Regional Analysis


The Americas dominate the global antihelminthics market owing to the increasing prevalence of people with parasitic diseases and presence of huge geriatric population. Additionally, well-developed technology, huge number of patients suffering from autoimmune diseases, and strong government support for research & development will fuel the market growth.


Europe is the second leading market across the globe, which is followed by Asia Pacific. Huge geriatric population, availability of funds for research, and government support for research & development will drive the market.


Asia Pacific is the fastest growing antihelminthics market due to the presence of huge patient pool, rapidly growing economy, increasing prevalence of digestive diseases, and presence of huge geriatric population. Some of the regions in the Asia Pacific is still lack the proper hygiene which has led to the growth of the market in this region.


On the other hand, the Middle East & Africa holds the least share of the market owing to limited availability of medical facilities, less availability of funds, and poor political conditions in Africa. Majority of the market of this region is held by Middle East due to a well-developed healthcare sector and huge healthcare expenditure.


Key Players


Some of key the players in the antihelminthics market are Abbott (US), Novartis AG (Switzerland), ZEISS International (Germany), Johnson & Johnson Services, Inc. (US), Sanofi (US), Merck & Co., Inc. (US), GlaxoSmithKline plc. (US), Astellas Pharma Inc. (Japan), Bayer AG (Germany), Mentis Pharma Ltd. (India), Pfizer Inc. (US), Sanofi (France), ALLERGAN (Ireland), and AstraZeneca (UK)


Intended Audience



  • Pharmaceutical and Biotechnological Companies

  • Research and Development (R&D) Companies

  • Ophthalmic Companies

  • Hospitals and Clinics

  • Academic Institutes and Universities



Report Scope:
Report Attribute/Metric Details
  Market Size   Significant Value
  CAGR   2017-2023: 5.3%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage    Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   By Types, application, and end user
  Geographies Covered    North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Abbott (US), Novartis AG (Switzerland), ZEISS International (Germany), Johnson & Johnson Services, Inc. (US), Sanofi (US), Merck & Co., Inc. (US), GlaxoSmithKline plc. (US), Astellas Pharma Inc. (Japan), Bayer AG (Germany), Mentis Pharma Ltd. (India), Pfizer Inc. (US), Sanofi (France), ALLERGAN (Ireland), and AstraZeneca (UK)
  Key Market Opportunities   Strong Government Support For Research & Development
  Key Market Drivers

  • Increasing geriatric population
  • Rapidly developing healthcare


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    antihelminthics market is projected to grow at approximately 5.3% CAGR during the assessment period (2017-2023).

    Rising demand for the treatment of parasitic diseases and the rising per capita healthcare expenditure, are major tailwinds pushing the growth of the global antihelminthics market.

    Reported cases of side effects observed during the treatment are major growth impeders for the global antihelminthics market.

    North America holds the largest share in the global antihelminthics market, followed by Europe and the Asia Pacific, respectively.

    Abbott (US), ZEISS International (Germany), Novartis AG (Switzerland), Johnson & Johnson Services, Inc. (US), Merck & Co., Inc. (US), Sanofi (US), GlaxoSmithKline plc (US), Bayer AG (Germany), Astellas Pharma Inc. (Japan), Mentis Pharma Ltd. (India), Sanofi (France), Pfizer Inc. (US), AstraZeneca (UK), and ALLERGAN (Ireland), are some of the top players operating in the global antihelminthics market.